• Therapeutic Cataract & Refractive
  • Lens Technology
  • Glasses
  • Ptosis
  • Comprehensive Eye Exams
  • AMD
  • COVID-19
  • DME
  • Ocular Surface Disease
  • Optic Relief
  • Geographic Atrophy
  • Cornea
  • Conjunctivitis
  • LASIK
  • Myopia
  • Presbyopia
  • Allergy
  • Nutrition
  • Pediatrics
  • Retina
  • Cataract
  • Contact Lenses
  • Lid and Lash
  • Dry Eye
  • Glaucoma
  • Refractive Surgery
  • Comanagement
  • Blepharitis
  • OCT
  • Patient Care
  • Diabetic Eye Disease
  • Technology

TearLab reports interim results of dry eye study

Article

TearLab recently reported interim results of a multi-center dry eye disease (DED) prevalence study carried out in the UK at four National Health Service (NHS) hospitals.

San Diego, CA-TearLab recently reported interim results of a multi-center dry eye disease (DED) prevalence study carried out in the UK at four National Health Service (NHS) hospitals.

Assess dry eye from a systemic standpoint

The study compared the effectiveness of the TearLab Osmolarity test to other traditional methods of diagnosing DED. The study began in March and its interim phase was completed in June. The interim clinical trial results showed that osmolarity had the highest agreement with the International Dry Eye Workshop (DEWS) findings, which is a composite score based on several tests, and that traditional tests like staining and TBUT do not correlate well with the presence of the disease.

“The interim results of this study could have far-reaching consequences for the evaluation, diagnosis, and management of dry eye disease in the UK,” lead investigator and consultant ophthalmologist Francesca Harman, from Hillingdon Hospital, said in a statement.

Related Videos
Megan Cavet, PhD
Andrew Pucker, OD, PhD
Dr. John Sheppard discusses results from trials testing the efficacy of eye drops to treat dry eye disease
Marc R Bloomenstein, OD, FAAO, chats with Optometry Times about the benefits of Vevye in the treatment of dry eye
R Tracy Williams, OD, FAAO, details his experience as a sports team optometrist
© 2024 MJH Life Sciences

All rights reserved.